LON:MCS - McCarthy & Stone Share Price, Forecast & News

McCarthy & Stone's stock was trading at GBX 118.50 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, MCS shares have decreased by 37.6% and is now trading at GBX 73.90. View which stocks have been mosted impacted by Coronavirus.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for McCarthy & Stone in the last year. There are currently 2 sell ratings, 2 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for McCarthy & Stone.

McCarthy & Stone PLC (LON:MCS) issued its earnings results on Tuesday, November, 13th. The company reported $9.20 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $9.70 by $0.50. View McCarthy & Stone's earnings history.

McCarthy & Stone declared a dividend on Tuesday, January 28th. Shareholders of record on Thursday, March 5th will be given a dividend of GBX 3.50 per share on Friday, April 3rd. This represents a yield of 2.25%. The ex-dividend date of this dividend is Thursday, March 5th. This is an increase from McCarthy & Stone's previous dividend of $1.90. The official announcement can be viewed at this link. View McCarthy & Stone's dividend history.

8 analysts have issued 12 month price objectives for McCarthy & Stone's shares. Their forecasts range from GBX 55 to GBX 190. On average, they expect McCarthy & Stone's stock price to reach GBX 140 in the next twelve months. This suggests a possible upside of 89.4% from the stock's current price. View analysts' price targets for McCarthy & Stone.

News articles about MCS stock have trended somewhat positive this week, InfoTrie reports. The research group rates the sentiment of press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. McCarthy & Stone earned a media sentiment score of 1.2 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View the latest news aboutMcCarthy & Stone.

Some companies that are related to McCarthy & Stone include Redrow (RDW), Vistry Group (VTY), Skyline (SKY), Crest Nicholson (CRST), Watkin Jones (WJG), MJ Gleeson (GLE), Telford Homes (TEF), Henry Boot (BOOT), Abbey (ABBY), Galliford Try (GFRD), Springfield Properties (SPR), Tamawood (TWD), Simonds Group (SIO), Boyuan Construction Group (BOY) and Cairn Homes (CRN).

Based on aggregate information from My MarketBeat watchlists, some companies that other McCarthy & Stone investors own include Telit Communications (TCM), Barratt Developments (BDEV), 3i Group (III), OneSavings Bank (OSB), Abercrombie & Fitch (ANF), Beach Energy (BPT), Amigo (AMGO), BAE Systems (BA), Chemring Group (CHG) and Man Group (EMG).

McCarthy & Stone trades on the London Stock Exchange (LON) under the ticker symbol "MCS."

Shares of MCS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

One share of MCS stock can currently be purchased for approximately GBX 73.90.

McCarthy & Stone has a market capitalization of £397.13 million and generates £621.43 million in revenue each year. McCarthy & Stone employs 2,512 workers across the globe. View additional information about McCarthy & Stone.

The official website for McCarthy & Stone is http://www.mccarthyandstonegroup.co.uk/.

McCarthy & Stone's mailing address is 4th Fl, 100 Holdenhurst Road, BOURNEMOUTH, BH8 8AQ, United Kingdom. The company can be reached via phone at 44 1202 292 480.